Clinical trial
A Study of Abicipar Pegol in Japanese Patients With Neovascular Age-related Macular Degeneration
NCT02181504 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of Abicipar Pegol in Japanese Patients With Neovascular Age-related Macular Degeneration
- Lead sponsor
- Allergan
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2014
- Completion date
- December 31, 2015
- Enrollment
- 25 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.